Latest Advanced Artificial Intelligence Methods for Machine Learning Model-Based Predictive Parkinson's Disease Identification

For these treatment and test data to have any significance or importance in the context of Parkinson's disease, the measures of the extent of the disease are hence quantitative, consistent, and repeatable. For the last half-century, a subjective emotional measure has governed human understanding of the phenotype of the disease during routine clinical visits. The work aimed to develop and validate artificial intelligence models for the identification of Parkinson's disease. The paper uses modern machine learning approaches to design an identification model for Parkinson's Disease tested on its subjects. Researchers employed an integrated dataset that combined clinical, genetic, and neuroimaging data for the diagnosis and control of Parkinson's disease. The performance on a predictive model implemented for better diagnostic accuracy and efficacy is used. The supervised learning algorithms Random Forest, Deep Neural Networks, and Support Vector Machines/SVM are exercised for the analysis and pattern recognition with PD. In this way, the possibility to point out several of the most important diagnostic discordant for both motor and non-motor symptoms, genetic markers, and neuroimaging results was established, which is critical for differentiating the complex clinical phenotypes of Parkinson's disease. An AI model, which was trained on a subset of this data, was validated using a different test set so as to verify the predictive capability of the model. Preliminary findings have shown that, on account of the high sensitivity, specificity, and extent of model appropriateness, the diagnostic model can be more effective than that of the conventional diagnostic methods.